Citigroup’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$77.2K Sell
14,220
-1,623
-10% -$8.81K ﹤0.01% 3817
2025
Q1
$55K Sell
15,843
-4,469
-22% -$15.5K ﹤0.01% 4080
2024
Q4
$209K Buy
20,312
+3,803
+23% +$39.1K ﹤0.01% 3558
2024
Q3
$224K Buy
16,509
+11,045
+202% +$150K ﹤0.01% 3502
2024
Q2
$71K Buy
5,464
+1,520
+39% +$19.8K ﹤0.01% 3663
2024
Q1
$37.2K Buy
3,944
+367
+10% +$3.47K ﹤0.01% 4028
2023
Q4
$39.2K Buy
3,577
+3,568
+39,644% +$39.1K ﹤0.01% 3903
2023
Q3
$58 Sell
9
-5,792
-100% -$37.3K ﹤0.01% 4736
2023
Q2
$27.9K Buy
+5,801
New +$27.9K ﹤0.01% 4193
2023
Q1
Sell
-414
Closed -$1.78K 4933
2022
Q4
$1.78K Buy
+414
New +$1.78K ﹤0.01% 4503